{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:32:15Z","timestamp":1785155535887,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04531-8","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:52:09Z","timestamp":1768031529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Caregiver burden in Duchenne muscular dystrophy in Europe, Japan, and the United States \u2013 a real-world study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jonathan","family":"Strober","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nate","family":"Posner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Cappelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Talaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Dukacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Chatterton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Weatherby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"de Courcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"1","key":"4531_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00007.2015","volume":"96","author":"DG Allen","year":"2016","unstructured":"Allen DG, Whitehead NP, Froehner SC. Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy. Physiol Rev. 2016;96(1):253\u2013305. https:\/\/doi.org\/10.1152\/physrev.00007.2015.","journal-title":"Physiol Rev"},{"issue":"8","key":"4531_CR2","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1007\/s00415-023-11796-x","volume":"270","author":"M Chang","year":"2023","unstructured":"Chang M, Cai Y, Gao Z, Chen X, Liu B, Zhang C, Yu W, Cao Q, Shen Y, Yao X, Chen X, Sun H. Duchenne muscular dystrophy: pathogenesis and promising therapies. J Neurol. 2023;270(8):3733\u201349. https:\/\/doi.org\/10.1007\/s00415-023-11796-x. Epub 2023 Jun 1 PMID: 37258941.","journal-title":"J Neurol"},{"issue":"1","key":"4531_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0631-3","volume":"12","author":"S Ryder","year":"2017","unstructured":"Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Dis. 2017;12(1):79. https:\/\/doi.org\/10.1186\/s13023-017-0631-3.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"4531_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S2213-2600(21)00581-6","volume":"10","author":"DJ Birnkrant","year":"2022","unstructured":"Birnkrant DJ, Bello L, Butterfield RJ, Carter JC, Cripe LH, Cripe TP, et al. Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges. Lancet Respir Med. 2022;10(4):403\u201320. https:\/\/doi.org\/10.1016\/S2213-2600(21)00581-6.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"4531_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/dmcn.13934","volume":"60","author":"E Landfeldt","year":"2018","unstructured":"Landfeldt E, Edstr\u00f6m J, Buccella F, Kirschner J, Lochm\u00fcller H. Duchenne muscular dystrophy and caregiver burden: a systematic review. Dev Med Child Neurol. 2018;60(10):987\u201396. https:\/\/doi.org\/10.1111\/dmcn.13934.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"4531_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-022-01941-x","volume":"20","author":"V Andreozzi","year":"2022","unstructured":"Andreozzi V, Labisa P, Mota M, Monteiro S, Alves R, Almeida J, et al. Quality of life and informal care burden associated with Duchenne muscular dystrophy in Portugal: the COIDUCH study. Health Qual Life Outcomes. 2022;20(1):36. https:\/\/doi.org\/10.1186\/s12955-022-01941-x.","journal-title":"Health Qual Life Outcomes"},{"issue":"19","key":"4531_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191912334","volume":"19","author":"AA Rodr\u00edguez","year":"2022","unstructured":"Rodr\u00edguez AA, Amayra I, L\u00f3pez-Paz JF, Mart\u00ednez O, Garc\u00eda M, Salgueiro M, et al. The role of associations in reducing the emotional and financial impact on parents caring for children with Duchenne muscular dystrophy: a cross-cultural study. Int J Environ Res Public Health. 2022;19(19):12334. https:\/\/doi.org\/10.3390\/ijerph191912334.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"4531_CR8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39597","volume":"15","author":"A Balidemaj","year":"2023","unstructured":"Balidemaj A, Parsamanesh P, Vysochyn M. Exploring the dynamics of caring for a child with a terminal illness of Duchenne muscular dystrophy (DMD) and its copious components on the caregivers. Cureus. 2023;15(5):e39597. https:\/\/doi.org\/10.7759\/cureus.39597. (PMID:37384074;PMCID:PMC10295810).","journal-title":"Cureus"},{"issue":"1","key":"4531_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s41687-021-00386-y","volume":"5","author":"CE Schwartz","year":"2021","unstructured":"Schwartz CE, Stark RB, Audhya IF, Gooch KL. Characterizing the quality-of-life impact of Duchenne muscular dystrophy on caregivers: a case-control investigation. J Patient Rep Outcomes. 2021;5(1):124. https:\/\/doi.org\/10.1186\/s41687-021-00386-y. PMID:34800189;PMCID:PMC8605451.","journal-title":"J Patient Rep Outcomes"},{"issue":"11","key":"4531_CR10","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes - a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372. https:\/\/doi.org\/10.1185\/03007990802457040.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"4531_CR11","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","volume":"39","author":"P Anderson","year":"2023","unstructured":"Anderson P, Higgins V, de Courcy J, Doslikova K, Davis VA, Karavali M, et al. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on disease specific programmes. Curr Med Res Opin. 2023;39(12):1707\u201315. https:\/\/doi.org\/10.1080\/03007995.2023.2279679.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"4531_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352","volume":"6","author":"SM Babineaux","year":"2016","unstructured":"Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the disease specific programme. BMJ Open. 2016;6(8):e010352. https:\/\/doi.org\/10.1136\/bmjopen-2015-010352.","journal-title":"BMJ Open"},{"key":"4531_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/DMSO.S120101","volume":"9","author":"V Higgins","year":"2016","unstructured":"Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016;9:371\u201380. https:\/\/doi.org\/10.2147\/DMSO.S120101.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"4531_CR14","unstructured":"EuroQoL. EQ-5D-5L. https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-5l-about\/. Accessed May 11, 2023."},{"key":"4531_CR15","doi-asserted-by":"publisher","unstructured":"Janssen B, Szende A. Population Norms for the EQ-5D. In: Szende A, Janssen B, Cabases J, editors. Self-Reported Population Health: An International Perspective based on EQ-5D. Dordrecht (NL): Springer; 2014. Chapter 3. PMID: 29787189. https:\/\/link.springer.com\/content\/pdf\/https:\/\/doi.org\/10.1007\/978-94-007-7596-1.pdf. Accessed May 11, 2023.","DOI":"10.1007\/978-94-007-7596-1.pdf"},{"issue":"5","key":"4531_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365. https:\/\/doi.org\/10.2165\/00019053-199304050-00006.","journal-title":"Pharmacoeconomics"},{"key":"4531_CR17","volume-title":"Fundamentals of Biostatistics","author":"B Rosner","year":"2015","unstructured":"Rosner B. Fundamentals of Biostatistics. 8th ed. Boston, MA: Cengage Learning; 2015.","edition":"8th ed"},{"key":"4531_CR18","unstructured":"StataCorp. Stata 17 Base Reference Manual. College Station: Stata Press;\u00a02021."},{"issue":"2","key":"4531_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mus.27532","volume":"66","author":"S Thomas","year":"2022","unstructured":"Thomas S, Conway KM, Fapo O, Street N, Mathews KD, Mann JR, et al. Time to diagnosis of Duchenne muscular dystrophy remains unchanged: findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000\u20132015. Muscle Nerve. 2022;66(2):193\u20137. https:\/\/doi.org\/10.1002\/mus.27532.","journal-title":"Muscle Nerve"},{"issue":"4","key":"4531_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3233\/JND-160185","volume":"3","author":"J Vry","year":"2016","unstructured":"Vry J, Gramsch K, Rodger S, Thompson R, Steffensen BF, Rahbek J, et al. European cross-sectional survey of current care practices for Duchenne muscular dystrophy reveals regional and age-dependent differences. J Neuromuscul Dis. 2016;3(4):517\u201327. https:\/\/doi.org\/10.3233\/JND-160185.","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"4531_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27289-2","volume":"13","author":"M Hiebeler","year":"2013","unstructured":"Hiebeler M, Thiele S, Reilich P, Bernert G, Walter MC. Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany. Sci Rep. 2013;13(1):179. https:\/\/doi.org\/10.1038\/s41598-022-27289-2.","journal-title":"Sci Rep"},{"issue":"3","key":"4531_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11136-019-02355-x","volume":"29","author":"SM Szabo","year":"2020","unstructured":"Szabo SM, Audhya IF, Malone DC, Feeny D, Gooch KL. Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review. Qual Life Res. 2020;29(3):593\u2013605. https:\/\/doi.org\/10.1007\/s11136-019-02355-x.","journal-title":"Qual Life Res"},{"issue":"1","key":"4531_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-023-00671-y","volume":"7","author":"IF Audhya","year":"2023","unstructured":"Audhya IF, Szabo SM, Bever A, O\u2019Sullivan F, Malone DC, Feeny D, et al. Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L. J Patient-Rep Outcomes. 2023;7(1):132. https:\/\/doi.org\/10.1186\/s41687-023-00671-y.","journal-title":"J Patient-Rep Outcomes"},{"key":"4531_CR24","unstructured":"Organisation for Economic Co-operation and Development (OECD). Health at a glance. 2019. https:\/\/www.oecd-ilibrary.org\/social-issues-migration-health\/health-at-a-glance-2019_4dd50c09-en. Accessed February 21, 2024."},{"issue":"6","key":"4531_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/WNL.0000000000000669","volume":"83","author":"E Landfeldt","year":"2014","unstructured":"Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al. The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology. 2014;83(6):529\u201336. https:\/\/doi.org\/10.1212\/WNL.0000000000000669.","journal-title":"Neurology"},{"key":"4531_CR26","unstructured":"COFACE Families Europe. Motherhood employment gap: shedding light on the vicious cycle. March 7, 2024. https:\/\/coface-eu.org\/motherhood-employment-gap\/. Accessed 9th September 2025."},{"key":"4531_CR27","unstructured":"USAFacts. How many moms are in the labor force? December 29, 2023. https:\/\/usafacts.org\/articles\/how-many-mothers-are-in-the-labor-force\/. Accessed 9th September 2025."},{"key":"4531_CR28","unstructured":"The Japan Times. Record 80% of Japanese mothers are employed. July 5, 2025. https:\/\/www.japantimes.co.jp\/news\/2025\/07\/05\/japan\/society\/japanese-mothers-jobs\/. Accessed 9th September 2025."},{"issue":"5","key":"4531_CR29","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s00415-016-8080-9","volume":"263","author":"E Landfeldt","year":"2016","unstructured":"Landfeldt E, Lindgren P, Bell CF, Guglieri M, Straub V, Lochm\u00fcller H, et al. Quantifying the burden of caregiving in Duchenne muscular dystrophy. J Neurol. 2016;263(5):906\u201315. https:\/\/doi.org\/10.1007\/s00415-016-8080-9.","journal-title":"J Neurol"},{"key":"4531_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-6-94","volume":"6","author":"DK Whynes","year":"2008","unstructured":"Whynes DK, TOMBOLA Group. Correspondence between EQ-5D health state classifications and EQ VAS scores. Health Qual Life Outcomes. 2008;6:94. https:\/\/doi.org\/10.1186\/1477-7525-6-94.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"4531_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-023-02115-z","volume":"21","author":"FS Teni","year":"2023","unstructured":"Teni FS, Burstr\u00f6m K, Devlin N, Parkin D, Rolfson O, Swedish Quality Register (SWEQR) Study Group. Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden. Health Qual Life Outcomes. 2023;21(1):34. https:\/\/doi.org\/10.1186\/s12955-023-02115-z.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"4531_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3233\/JND-230220","volume":"11","author":"E Landfeldt","year":"2024","unstructured":"Landfeldt E, Alem\u00e1n A, Abner S, Zhang R, Werner C, Tomazos I, et al. Predictors of loss of ambulation in Duchenne muscular dystrophy: a systematic review and meta-analysis. J Neuromuscul Dis. 2024;11(3):579\u2013612. https:\/\/doi.org\/10.3233\/JND-230220.","journal-title":"J Neuromuscul Dis"},{"issue":"6","key":"4531_CR33","doi-asserted-by":"publisher","first-page":"e1559","DOI":"10.1542\/peds.2012-0858","volume":"130","author":"K Uzark","year":"2012","unstructured":"Uzark K, King E, Cripe L, Spicer R, Sage J, Kinnett K, Wong B, Pratt J, Varni JW. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy. Pediatrics. 2012;130(6):e1559\u201366. https:\/\/doi.org\/10.1542\/peds.2012-0858. Epub 2012 Nov 5 PMID: 23129083.","journal-title":"Pediatrics"},{"key":"4531_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2023.10.018","volume":"151","author":"A Jesus","year":"2024","unstructured":"Jesus A, Bennett C, Masterson C, Brenner L, Scharf R. Self- and caregiver-reported participation, quality of life, and related mood and behavior challenges in people living with dystrophinopathies. Pediatr Neurol. 2024;151:37\u201344. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.10.018.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"4531_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/0272989X20978390","volume":"41","author":"NL Crossnohere","year":"2021","unstructured":"Crossnohere NL, Fischer R, Lloyd A, Prosser LA, Bridges JFP. Assessing the appropriateness of the EQ-5D for Duchenne muscular dystrophy: a patient-centered study. Med Decis Making. 2021;41(2):209\u201321. https:\/\/doi.org\/10.1177\/0272989X20978390.","journal-title":"Med Decis Making"},{"issue":"9","key":"4531_CR36","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.7326\/m22-1460","volume":"175","author":"LM DeTora","year":"2022","unstructured":"DeTora LM, Toroser D, Sykes A, Vanderlinden C, Plunkett FJ, Lane T, et al. Good publication practice (GPP) guidelines for company-sponsored biomedical research: 2022 update. Ann Intern Med. 2022;175(9):1298\u2013304. https:\/\/doi.org\/10.7326\/m22-1460.","journal-title":"Ann Intern Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04531-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:17:03Z","timestamp":1770391023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04531-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4531"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04531-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with relevant guidelines and followed the principles of the Helsinki Declaration of 1964 and subsequent revisions. The research was submitted to the Pearl Institutional Review Board, study protocol number #22-ADRW-162.Using a checkbox, caregivers provided informed consent to take part in the survey. Data were collected in such a way that patients, caregivers and physicians could not be identified directly. Data related to physicians, caregivers and people with DMD were pseudo-anonymized. A code was assigned when data were collected. Upon receipt by ARW, data were pseudo-anonymized again to mitigate against tracing them back to the individual. Data were aggregated before being shared with the subscriber and\/or for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JS is on the advisory board for Sarepta, speaker training for NS Pharma, was PI for Fibrogen pamrevlumab phase 2 trial and currently PI for PTC ataluaren phase 3. JS is also a speaker bureau for Biogen, consultant for UCB and Janssen\/Momenta, and PI for Janssen and Alexion. KI received honoraria for speakers bureaus from Nippon Shinyaku Co., Ltd and has an advisory role at Pfizer Japan Inc. JCC and NP are employees and stockholders of Pfizer Inc. SX, AT and SD are employees of Pfizer and may own stocks\/shares of the company. EC, EM, SW and JdC are full-time employees of Adelphi Real World, which received funding from Pfizer in connection with the development of this manuscript. HI no longer works for Adelphi Real World but did at the time of writing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}